Not all people with CLL call for therapy. Even with all modern advances, the iwCLL nonetheless suggests watchful observation for people with asymptomatic illness.86 This advice relies on at the least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).. intolerance).